Literature DB >> 32202813

Assessment of demand for methamphetamine and cigarettes among individuals with methamphetamine use disorder.

Jin H Yoon1, Robert Suchting1, Rachel N Cassidy2, Peter K Bolin3, Yasmine Omar3, Gregory S Brown4, Richard De La Garza3.   

Abstract

Methamphetamine (MA) is a highly addictive stimulant with recent upward trends in prevalence and associated public health problems. Drug demand, as assessed by hypothetical purchasing tasks, has been useful in addictions research and may help our understanding of the factors influencing MA use. However, no studies have assessed MA demand using current models of demand. The purpose of the current study was to assess demand for MA using a hypothetical drug purchasing task. Given high rates of cigarette smoking among MA users, it was of interest also to assess and compare demand for MA relative to cigarettes. Participants consisted of non-treatment-seeking volunteers with MA use disorder (N = 18), of whom 17 reported daily smoking. Results showed the exponentiated demand model provided a good fit to consumption data. Results from Bayesian generalized linear modeling demonstrated multiple positive relationships (posterior probability ≥75%) between self-reported drug use (days MA used in the past 30 days, cigarettes smoked per day) and indices of demand for each drug (Qo, Omax, Pmax, and break point). Comparing MA to cigarettes, results from Bayesian generalized linear mixed modeling revealed greater abuse liability for MA compared to cigarettes (posterior probability ≥99%) based on α and essential value. Overall, the findings of the current study support the feasibility and validity of the exponentiated demand model for assessing demand for drugs among individuals with MA use disorder. (PsycInfo Database Record (c) 2021 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32202813      PMCID: PMC7508771          DOI: 10.1037/pha0000367

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.492


  52 in total

1.  Rivastigmine reduces "Likely to use methamphetamine" in methamphetamine-dependent volunteers.

Authors:  R De La Garza; T F Newton; C N Haile; J H Yoon; C S Nerumalla; J J Mahoney; A Aziziyeh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2011-12-30       Impact factor: 5.067

2.  Comparison of three measurement models of discounting among individuals with methamphetamine use disorder.

Authors:  Jin H Yoon; Matthew T Weaver; Richard De La Garza; Robert Suchting; Chandra S Nerumalla; Yasmine Omar; Gregory S Brown; Ilana Haliwa; Thomas F Newton
Journal:  Am J Addict       Date:  2018-07-19

3.  Comparing exponential and exponentiated models of drug demand in cocaine users.

Authors:  Justin C Strickland; Joshua A Lile; Craig R Rush; William W Stoops
Journal:  Exp Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.157

Review 4.  The behavioral economics of substance use disorders: reinforcement pathologies and their repair.

Authors:  Warren K Bickel; Matthew W Johnson; Mikhail N Koffarnus; James MacKillop; James G Murphy
Journal:  Annu Rev Clin Psychol       Date:  2014       Impact factor: 18.561

5.  The effect of methamphetamine and heroin price on polydrug use: A behavioural economics analysis in Sydney, Australia.

Authors:  Jenny Chalmers; Deborah Bradford; Craig Jones
Journal:  Int J Drug Policy       Date:  2010-07-08

6.  Low dose, short-term rivastigmine administration does not affect neurocognition in methamphetamine dependent individuals.

Authors:  Ari D Kalechstein; Jin H Yoon; Daniel E Croft; Susanne Jaeggi; James J Mahoney; Richard De La Garza
Journal:  Pharmacol Biochem Behav       Date:  2011-05-23       Impact factor: 3.533

7.  Cigarette demand and delayed reward discounting in nicotine-dependent individuals with schizophrenia and controls: an initial study.

Authors:  James MacKillop; Jennifer W Tidey
Journal:  Psychopharmacology (Berl)       Date:  2011-02-16       Impact factor: 4.530

8.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

Authors:  T F Heatherton; L T Kozlowski; R C Frecker; K O Fagerström
Journal:  Br J Addict       Date:  1991-09

9.  Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers.

Authors:  Richard De La Garza; Todd Zorick; Edythe D London; Thomas F Newton
Journal:  Drug Alcohol Depend       Date:  2009-09-24       Impact factor: 4.492

10.  Subjective and Cardiovascular Effects of Intravenous Methamphetamine during Perindopril Maintenance: A Randomized, Double-Blind, Placebo-Controlled Human Laboratory Study.

Authors:  Christopher D Verrico; Colin N Haile; Richard De La Garza; Kenneth Grasing; Thomas R Kosten; Thomas F Newton
Journal:  Int J Neuropsychopharmacol       Date:  2016-07-05       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.